Reply to: The potential and challenges of radiomics in uncovering prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis

Abstract

We thank L. Zhang and co-workers for their correspondence regarding our manuscript. In interstitial lung disease associated with systemic sclerosis (SSc-ILD), the lack of valid prognostic biomarkers hampers individualised patient management. Our study introduces radiomics as a novel non-invasive tool to acquire phenotypic, prognostic and molecular information derived from standard-of-care high-resolution computed tomography images with great potential to support clinical decision making in SSc-ILD [1].